Outcomes from active surveillance have clearly shown that it is the optimal method of managing many early prostate cancers. Yet, clinician training and healthcare systems are still primarily focused on the “need to treat”. This comment explores the challenges and resource issues in future implementation of high-quality surveillance programmes.
No takes yet. Share an insight, caveat, or question.
Vincent J. Gnanapragasam (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: